Contraceptive Technology Update – December 1, 2002
December 1, 2002
View Issues
-
Family planning facilities meet the challenge of Lunelle syringe recall
If a large segment of your patient population is using the monthly contraceptive injection Lunelle, chances are that the last few weeks have been filled with contacting patients, answering questions, and counseling on backup contraception after the manufacturer issued a voluntary recall of prefilled syringes of the product. -
Bone loss in DMPA users mostly reversible
Add just-published research to your counseling on Depo-Provera (depot medroxyprogesterone acetate or DMPA): Use of the injectable contraceptive is strongly associated with bone density loss; however bone loss appears to be largely reversible once the injections are stopped.1 -
OCs and weight gain: It’s time to banish the myths
When reviewing birth control options with a teen-age female patient, she tells you that she doesnt want to use the Pill because it will make her gain weight. What do you tell her? -
Condom errors common among college-age men
In discussing condom use, your college-age male patient tells you that he uses protection on a regular basis. But is he using condoms correctly? -
Pill options expand with new, generic OCs
As 2002 comes to a close, get ready to add a new lower-dose version of a popular oral contraceptive (OC) to your list of pills, and look to the upcoming 2003 introduction of a generic form of a long-time Pill favorite. -
Washington Watch: Administration defunds U.N. Population Fund
This summer, the Bush administration officially announced it was cutting off all U.S. support for the United Nations Population Fund (UNFPA), the largest multilateral population assistance agency in the world. -
2002 Salary Survey Results: Family planning providers hold the line on salaries in 2002
Take a look at your paycheck; chances are if you are in the family planning field, it shows a slight increase from 2001.